Market Overview

UPDATE: Compass Point Upgrades DR Horton to Neutral on Updated Forecasts

Share:
Related DHI
Raymond James' Mass Downgrade Of Homebuilders Shows...It Doesn't Like Them Very Much
Friday's After-Hours Movers: Bojangles, Lululemon And More
Tracking David Tepper's Appaloosa Management Portfolio - Q1 2015 Update (Seeking Alpha)

Compass Point raised its rating on DR Horton (NYSE: DHI) from Sell to Neutral and raised its price target to $18.50.

Compass Point commented, "After a full model update we are raising estimates and, coupled with the stock's relative underperformance in the post-QE3 trade, we now feel DHI should perform in line with the rest of the space. Our price target increase reflects our increased 2013 EPS estimate to $0.93 from $0.87 as well as a consistent 5% assumed ROI. We still see downside in the shares to $18 but the stock is off 12% since the Fed announced QE3 in early September and has been the second worst performer in the homebuilding sector over that time frame."

DR Horton closed at $19.58 on Wednesday.

Latest Ratings for DHI

DateFirmActionFromTo
May 2015BarclaysMaintainsEqual-weight
Apr 2015CitigroupMaintainsNeutral
Apr 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for DHI
View the Latest Analyst Ratings

Posted-In: Compass PointAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (DHI)

Around the Web, We're Loving...